University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 9 of 35
Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabetes
NCT07116902
RCT of HeartBot in Women
NCT07416734
The Effects of Audio-Based Therapy on Anxiety in Psoriasis
NCT07390487
Brain Health Project for Korean American Dementia Caregivers
NCT06928454
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
NCT06078527
Conectados: Social Networks and Social Media for Vaccine Uptake
NCT07096245
Esophageal Manometry During Recovery From Endotracheal Intubation
NCT05574465
Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant
NCT06953336
Primary Care-based Study of an Online Workshop for Family Caregivers of PLWD
NCT06928467
Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa
NCT06849830
Addressing the Nutritional Needs of Cancer Survivors With Nutrition Insecurity
NCT06602999
Patient Agreement Form and Medication Abortion Knowledge
NCT07604675
Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)
NCT06651957
Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients
NCT06366217
An App-based Instructional Platform to Improve Eye Drop Recall
NCT06045390
Enhanced SUPport for Initiation and paRticipation in a FOOD is Medicine Program
NCT06500962
Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches
NCT06495580
Transforming Health and Reducing Perinatal Anxiety Through Virtual Engagement
NCT06404450
ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery
NCT06501716
Social Media Vaping Cessation Pilot With Peer Mentors
NCT07437196
Diet and Depression
NCT06252701
Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis
NCT06164470
Getting INFORMED and Living Well Among Asian Americans in California
NCT05968300
Comparison of Produce Prescription Benefit Dosage
NCT05978843
Heart Failure Polypill at a Safety Net Hospital
NCT06029712
Examining Transcutaneous Vagal Nerve Stimulation as a Facilitator of Social Bonding
NCT05899413
NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
NCT06000748
Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis
NCT06276387
PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED
NCT06156215
The SCULPT-Job Cohort Study
NCT06965075
Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
NCT05829824
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
NCT05746195
Virtual Reality as a Postoperative Pain Management Adjunct in Older Adults: An Acceptability and Feasibility Study
NCT06095661
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
NCT05158166
A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients
NCT05928624
Contingency Management in HIV Care for Both Stimulant Use & ART Adherence
NCT06564792
PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men
NCT05353283
Intervention Utilizing a Computerized Cognitive Rehabilitation Program (D-kit/EF1)
NCT05933005
Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling
NCT05972109
UCSF BP Activate Letter Study
NCT06152094
Measuring rTMS-induced Neuroplasticity With EEG Steady-state Visual-evoked Potentials
NCT05853939
Genetic Testing in Autosomal Dominant Polycystic Kidney Disease
NCT06085807
The Resilience Clinic Evaluation
NCT05690256
Group-based Integrative Pain Management (IPMP+ Pilot)
NCT05906784
Enhanced Stress Resilience Training for Critical Care Nurses
NCT05905991
Studying the Modification of Attention Bias Remotely After Trauma
NCT04888169
Remote Monitoring for Equity in Advancing Control of Hypertension
NCT05481892
Impact of Topical Tranexamic Acid in Breast Reconstruction
NCT05807074
Brain Health Together: A Live-Streaming Group-Based Digital Program
NCT05818423
Optimizing Mindfulness Based Cognitive Therapy (MBCT) Maintenance
NCT05859386
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.